Fresenius Medical Care (NYSE:FMS) Shares Gap Up - Here's Why

Fresenius Medical Care AG (NYSE:FMS - Get Free Report) shares gapped up prior to trading on Thursday . The stock had previously closed at $24.73, but opened at $25.85. Fresenius Medical Care shares last traded at $25.74, with a volume of 96,490 shares trading hands.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on FMS. Truist Financial upped their target price on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the stock a "hold" rating in a research note on Monday, January 6th. StockNews.com raised Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 5th.

Fresenius Medical Care Stock Down 2.0 %

The firm's 50 day simple moving average is $24.11 and its 200-day simple moving average is $22.70. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $13.35 billion, a price-to-earnings ratio of 18.75, a price-to-earnings-growth ratio of 0.76 and a beta of 0.93.

Institutional Trading of Fresenius Medical Care

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC increased its position in shares of Fresenius Medical Care by 192.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after purchasing an additional 806 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Fresenius Medical Care in the third quarter valued at $38,000. Russell Investments Group Ltd. increased its holdings in Fresenius Medical Care by 234.1% during the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company's stock worth $71,000 after buying an additional 2,208 shares during the last quarter. Jones Financial Companies Lllp raised its position in Fresenius Medical Care by 80.5% during the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company's stock worth $102,000 after acquiring an additional 2,012 shares in the last quarter. Finally, Venturi Wealth Management LLC lifted its stake in Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock valued at $129,000 after acquiring an additional 441 shares during the last quarter. Institutional investors own 8.37% of the company's stock.

Remove Ads

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.